Altcoins like Ethereum, Bitcoin Cash, and ZCash are currently struggling for survival and analysts don’t expect them to grow in value. Are we witnessing an altcoin apocalypse or is this crypto bear market just a blip?
The Born2Invest application is collecting business news from various trusted sources. You can find information about cryptocurrency and blockchain, economy, investing, markets, media, and personal finance.
The application is optimized and designed in a way that you can always find the necessary information.
2019 was a bad year for most altcoins
As 2019 is coming to an end one thing is clear, the altcoin golden age is at an end. Two years ago the word ICO was on everyone’s lips.
In 2017, FOMO was the daily companion of every new investor and scammers took advantage and reaped huge rewards with fake ICOs and abandoned projects. Almost daily a new “Bitcoin killer” hit the market. However, few, if any, followed through on that promise.
Prior to the 2017 ICO rush, there were already a number of well-established altcoins of varying pedigree, like Ethereum, Ripple, Bitcoin Cash, ZCash and IOTA. Most of these coins hit their all-time high in 2017 and most have experienced a sustained decline since then.
Ethereum is 89% below its all-time high. This applies both to the pair ETH/USD and ETH/BTC. Bitcoin Cash is 95% below its all-time high in US dollars.
The most relevant example is probably ZCash. The anonymous cryptocurrency, which was among the top 20 coins for a long time, has lost almost ‘everything’ in value compared to Bitcoin.
ZCash is currently 98% below its all-time high in US dollars. Looking at the ZEC/BTC currency pair, ZCash lost 99.98%.
Some altcoins still have a high ROI
Almost all altcoins have seen a significant drop since then and have performed significantly worse than Bitcoin, which is around 63% below its all-time high, but the return on investment for early investors is still significant.
Ethereum, XRP or IOTA have all had an enormously strong Return-On-Investment (ROI) value. All three altcoins have gained hundreds and thousands of percent since their ICO.
However, only a few investors were able to benefit from this price increase – most of them probably have exited in the boom year 2017.
Bitcoin increasing in price
Some of the altcoins have held their positions over the last two years. Ethereum, XRP, Bitcoin Cash and Litecoin are still in the Top10. While Bitcoin has been able to increase its share price by more than 100% since August 5, 2017, the situation is much worse for most altcoins. No matter if it is Ethereum, Bitcoin Cash or IOTA.
Currently, the prices of the respective altcoin are a good 50% below the values at that time. Of course, at the end of December 2017, we saw abnormal prices for the altcoins.
Even those coins that performed ‘well’ did not achieve significant gains over time. At the moment, Litecoin is trading at pretty much the same price as on August 5, 2017. XRP rose from $0.18 to $0.21 during this period, up 15%.
Bitcoin vs. altcoin – the bottom line is Buy BTC
From a price and technical point of view, some of the featured altcoins such as Bitcoin Cash, or ZCash have been failures. Bitcoin Cash has an ROI of -62%. ZCash is -98%.
While other altcoins such as Ethereum or XRP have provided tremendous returns for those who bet on them, neither coin has been able to outperform Bitcoin in recent years.
The current market capitalization of the entire crypto market is almost $200 billion – on August 5, 2017, it was about $100 billion.
While the MarketCap has now doubled, Ethereum, XRP, and Co. have had to lose a lot in market capitalization. However, one of the coins that have benefited massively from this growth is Bitcoin.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in CRYPTOMONDAY, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Your 2020 guide on how to get the most out of video marketing
Video content marketing has increased in popularity. From ways to incorporate engaging footage into your campaigns, to the latest social...
The biggest estate planning blunders of all time
About 55% of Americans do not have a will. Even more worrisome is the fact that less than 1 in...
These marijuana stocks are gaining traction among Gen Z
Members of generation Z are utilizing their not-inconsiderable buying power in unique ways that are different than any generation before...
Could ElsaLys Biotech have a breakthrough treatment for Graft-verses-host disease?
ElsaLys Biotech is an immuno-oncology company that designs a new generation of therapeutic antibodies that target tumors and their immune...
Senegal’s Banks look to target the African disporia in the West
Remittances from relatives or friends living abroad represent an essential lifeline for many families in Sub-Sarah Africa. For example Senegalese...
- Crypto5 days ago
How blockchain technology is disrupting gambling
- Featured6 days ago
“As the World Turns” – a forecast for what might happen in the world economy this week
- Featured6 days ago
Great expectations for gold, silver and the precious metals mining companies in 2020
- Crowdfunding5 days ago
How crowdfunding helped this gaming company succeed